10:43 AM EST - Avalon GloboCare Corp. : Announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Publication for U.S. Patent No. 11,555,060, titled “QTY Fc Fusion Water Soluble Receptor Proteins.” The patent covers the composition of matter and methodology for multiple novel QTY-Code modified cytokine and chemokine protein receptor molecules. The patent was jointly filed with Dr. Shuguang Zhang of the Massachusetts Institute of Technology (MIT). Avalon GloboCare Corp.
shares N.ALBT are trading up 23 cents at $1.23.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ALBT&qmodStoryID=5136964045453122
